Radiopharm Theranostics Files 6-K for June 2025
Ticker: RDPTF · Form: 6-K · Filed: Jun 11, 2025 · CIK: 1949257
| Field | Detail |
|---|---|
| Company | Radiopharm Theranostics Ltd (RDPTF) |
| Form Type | 6-K |
| Filed Date | Jun 11, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: reporting, foreign-private-issuer, sec-filing
TL;DR
Radiopharm Theranostics filed a 6-K on June 11, 2025, confirming its foreign private issuer status and 20-F filing for annual reports.
AI Summary
Radiopharm Theranostics Limited filed a Form 6-K on June 11, 2025, reporting information for the month of June 2025. The filing indicates the company is a foreign private issuer and will file its annual reports under Form 20-F. The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Why It Matters
This filing provides routine updates for foreign private issuers, informing investors about the company's reporting status and administrative details.
Risk Assessment
Risk Level: low — This is a routine administrative filing for a foreign private issuer and does not contain new material financial or operational information.
Key Players & Entities
- Radiopharm Theranostics Limited (company) — Registrant
- 001-41621 (company) — Commission File Number
- Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia (company) — Principal executive office address
- Form 20-F (company) — Annual report form
- June 2025 (date) — Reporting period
FAQ
What is the purpose of this Form 6-K filing?
This Form 6-K is a Report of Foreign Private Issuer filed pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934, for the month of June 2025.
What is Radiopharm Theranostics Limited's commission file number?
Radiopharm Theranostics Limited's commission file number is 001-41621.
Where is Radiopharm Theranostics Limited's principal executive office located?
The company's principal executive office is located at Level 3, 62 Lygon Street, Carlton South, Victoria, 3053, Australia.
Under which form will Radiopharm Theranostics Limited file its annual reports?
Radiopharm Theranostics Limited will file its annual reports under cover of Form 20-F.
Is Radiopharm Theranostics Limited furnishing information under Rule 12g3-2(b)?
No, the registrant is not furnishing information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934, as indicated by the 'No' checkbox being marked.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on June 11, 2025 regarding Radiopharm Theranostics Ltd (RDPTF).